Lung cancer is a malignant tumour of the lungs. Most commonly it is bronchogenic carcinoma (about 90%). Lung cancer is the most lethal malignant tumour worldwide. Although exposure to asbestos alone can lead to lung cancer, the risk increases dramatically in persons who smoke cigarettes or other forms of tobacco.
Lack of a protein in lung tumors may increase risk of death
Lung Cancer :: Lack of a protein in lung tumors may increase risk of death
A study of human lung tumors indicates that lung cancer patients who lack a particular protein may do more poorly than those with normal levels of that same protein.The protein is the product of a gene called Olig1, which previously has not been linked with lung cancer, and it is located in a chromosome region that is often lost in the tumor cells of many lung-cancer patients.
The research examined tumors from people with non-small cell lung cancer (NSCLC), the most common form of lung cancer. It sought to identify genes that are turned off, or silenced, by a process called aberrant DNA methylation.
The study wanted to learn if the pattern of silenced genes could distinguish between two subtypes of NSCLC, adenocarcinoma and squamous cell carcinoma.
The research identified 47 genes that together can differentiate between the two lung cancer subtypes. It also found that the silencing of the Olig1 gene ? which results in the absence or low levels of its protein product ? was linked to poor survival in NSCLC patients.
The study, led by researchers at the Ohio State University Comprehensive Cancer Center, is published in the March 27 issue of PLoS Medicine.
"We found that when the Olig1 protein is down-regulated or absent, the risk of death is significantly higher compared with patients who have normal levels of the protein," says first-author Romulo M. Brena, a graduate research associate in molecular genetics and in molecular virology, immunology and medical genetics.
"Even low levels of the protein were associated with better survival," he says.
The findings might have important clinical significance, says coauthor Gregory Otterson, associate professor of internal medicine and a medical oncologist who specializes in lung cancer treatment.
"This study identified a novel gene that had no known role in lung cancer development and that is silenced in a large number of patients," says Otterson, also a researcher with the Ohio State University Comprehensive Cancer Center . "The absence of the protein may have important prognostic implications."
Lung cancer is the leading cause of cancer illness and death worldwide. Every year, an estimated 1.2 million people are diagnosed with the malignancy, and 1.1 million others die from the disease. More than 85 percent of these cases are NSCLC.
Presently, a lung-cancer patient's prognosis is based on how far the disease has progressed, which is determined by staging the disease.
"There is a high correlation between survival and a patient's stage," Brena says. "But there is also wide variation in overall survival among patients who are in the same stage. Some live for only a short time, others for a longer time.
"We don't know why that is, but it is probably related to the molecular and genetic characteristics of the tumor," he says. "The presence or absence of Olig1 may be one of those characteristics."
An analysis of patient survival data indicated that patients with little or no Olig1 in their tumor cells had about a 15 percent decrease in survival.
The researchers are now trying to learn the role of the Olig1 gene and protein in lung cells and how their loss may contribute to cancer development.
(Lung Cancer :: Lack of a protein in lung tumors may increase risk of death published at SpiritIndia on Monday, March 26, 2007)
Lung Cancer
Search more information on Lung Cancer, Lung Cancer booksRecently posted related articles on Lung Cancer :
- Lung Cancer :: Tumor genome analysis unveils new insights into lung cancer
- Lung Cancer :: Study identifies novel gene alterations in lung cancer
- Lung Cancer :: GSK's Hycamtin, topotecan capsules approved for treatment of small cell lung cancer
- Lung Cancer :: CSHL researchers discover three new genes that cause lung cancer
- Lung Cancer :: Studies suggest key correlation between lung cancer subtype and treatment outcomes
- Lung Cancer :: Lilly's Alimta for Lung Cancer in Europe
- Lung Cancer :: Blood protein detects lung cancer at earliest stage
- Lung Cancer :: Immune system gene may influence lung cancer survival
- Lung Cancer :: New lung cancer guidelines oppose general CT screening
- Arthritis :: Knee arthritis link to lung cancer
Most related articles:
- Lung Cancer :: Lack of a protein in lung tumors may increase risk of death- Lung Cancer :: New antibody for EGFR causes lung cancer regression - 13.6
- Cancer :: New biomarkers allow physicians to personalize lung or brain cancer therapy - 12.2
- Lung Cancer :: Don't delay treatment in stage I lung cancer - 12
- Lung Cancer :: Researchers find declining trend in lung tumors - 11.7
- Lung Cancer :: Modeling lung cancer - 11.4
- Lung Cancer :: Lung cancer may be hereditary, study shows - 11
- Lung Cancer :: Annual CT scan for lung cancer offers new hope - 11
- Lung Cancer :: Statins shown to prevent lung cancer - 10.9
- Lung Cancer :: Crunchy Veggies May Thwart Lung Cancer - 10.9
Lung Cancer - recent related articles/news stories:
- Surgery remans an option for lung cancer patients- Thalidomide does not improve survival in lung cancer
- Lilly's lung cancer drug Alimta is approved in US
- Vandetanib with docetaxel improve lung cancer survival
- Stem cell clue to lung cancer development
»» HIV :: Cornell researcher helping develop quick, cheap HIV AIDS test
«« Screening :: Preventive health exams may provide opportunities for cancer screening
The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com